BRCANOW® is a next-generation sequencing panel for people with a personal or family history of breast or ovarian cancer.
For hereditary screening, we offer two versions of the BRCANOW® test, BRCANOW® Basic and BRCANOW® Extended, with reflex options available. In addition to BRCA1 & BRCA2, which account for the majority of hereditary breast and ovarian cancers, the BRCANOW®
Extended panel includes additional genes that are less common but known to be associated with hereditary breast and ovarian cancers. Both versions of the assay utilize next-generation sequencing to detect single- and multi-nucleotide substitutions and small insertions and deletions in coding regions and exon-intron junctions, as well as large genomic rearrangements of the target genes, providing >1500X average coverage at the targeted genomic regions of the tested genes.